Physician profile
Mark J Abraham
NPI 1508829656
$30,062.14
in general payments reported to CMS, 2019-2025
21 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,464 · 2020: $462 · 2021: $1,341 · 2022: $11K · 2023: $8,121 · 2024: $1,056 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,884 · Food and Beverage: $3,588 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,883.79 |
| Food and Beverage | $3,588.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $18,698.99 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $8,155.03 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $2,218.02 | 2019-2025 | Acuvue |
| Dompe US, INC. | $210.27 | 2019-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $120.45 | 2025 | |
| Rxsight INC | $111.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $65.90 | 2019-2022 | |
| Alcon Research LLC | $64.72 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $64.39 | 2019-2021 | |
| Sight Sciences, INC. | $57.12 | 2022-2024 | Tearcare System |
| Carl Zeiss Meditec USA, INC. | $46.15 | 2023 | Clarus |
| Abbvie INC. | $40.55 | 2022 | |
| Biotissue Holdings INC. | $38.43 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $35.89 | 2024 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $26.54 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $23.87 | 2024 | Miebo |
| Allergan, INC. | $19.53 | 2020 | |
| Visioneering Technologies, INC. | $17.76 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Aerie Pharmaceuticals, INC. | $14.84 | 2019 | |
| Shire North American Group INC | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.